News · CNBC · Nov 6, 2026
Could CRISPR cure rare diseases before birth? Scientists are getting closer
Publisher excerpt · CNBC
Researchers are exploring fetal gene editing to treat rare genetic disorders before they cause lasting damage.
Research this headline
The Open Stock is not the publisher. Market-data APIs only send the headline and a short CNBC summary — not the full story. This page exists so DIY investors can jump from names in the wire to free charts, financials, and forecasts.
No listed US ticker was detected in this headline. Search from the home page if you want a chart for a name in the CNBC story.
Cite CNBC as the reporter. The Open Stock is a news aggregator — we do not publish this story. Mentioned tickers open free charts on this site.
Looking for another ticker? Search on the home page.